Documente Academic
Documente Profesional
Documente Cultură
Acne vulgaris is a common chronic skin disease involving blockage and/or inflammation
of pilosebaceous units (hair follicles and their accompanying sebaceous gland). Acne can
present as noninflammatory lesions, inflammatory lesions, or a mixture of both, affecting
mostly the face but also the back and chest.[1]See the image below.
Acne vulgaris has a multifactorial pathogenesis, of which the key factor is genetics.[2]
Acne develops as a result of an interplay of the following four factors: (1) follicular
epidermal hyperproliferation with subsequent plugging of the follicle, (2) excess sebum
production, (3) the presence and activity of the commensal bacteriaPropionibacterium
acnes, and (4) inflammation.[3]
Diagnosis
Examination in patients with acne vulgaris includes the following features:
Comedonal acne: Presence of open and closed comedones but usually no inflammatory papules or
nodules
Moderate acne: Presence of comedones, inflammatory papules, and pustules; a greater number of
lesions are present than in milder inflammatory acne
Nodulocystic acne: Presence of comedones, inflammatory lesions, and large nodules greater than 5
mm in diameter; scarring is often evident
Laboratory tests
Acne vulgaris is a clinical diagnosis. However, laboratory testing may be indicated in the
following situations:
Female patients with dysmenorrhea or hirsutism: Consider a hormonal evaluation with levels of total
and/or free testosterone, dehydroepiandrosterone sulfate, luteinizing hormone, and folliclestimulating hormone
Cases refractory to treatment or when improvement is not maintained: Culture skin lesions to rule
out gram-negative folliculitis
Management
Treatment of acne vulgaris should be directed toward the known pathogenic factors,
including follicular hyperproliferation, excess sebum, P acnes, and inflammation. The
most appropriate treatment is based on the grade and severity of the acne.
Pharmacotherapy
The following medications are used in the treatment of Propionibacterium acne vulgaris:
Estrogen/progestin combination oral contraceptive pills (eg, ethinyl estradiol, drospirenone, and
levomefolate; ethinyl estradiol and norethindrone; ethinyl estradiol and norgestimate; ethinyl
estradiol and drospirenone)
Acne products (eg, erythromycin and benzoyl peroxide, clindamycin and tretinoin, clindamycin and
benzoyl peroxide, azelaic acid, benzoyl peroxide)
Background
Acne vulgaris is characterized by noninflammatory, open or closed comedones and by
inflammatory papules, pustules, and nodules. Acne vulgaris typically affects the areas of
skin with the densest population of sebaceous follicles; these areas include the face, the
upper part of the chest, and the back.
Acne vulgaris is the most common skin disease in the United States; it affects an
estimated 80% of Americans at some time during their lives.[5]Twenty percent have
severe acne, which can result in permanent physical and mental scarring.
Medscape Reference articles on acne include Acne Conglobata,Acne Fulminans,Acne
Keloidalis Nuchae, and Acneiform Eruptions. Also see the Medscape Acne Resource
Center.
Pathophysiology
Epidemiology
United States
Acne vulgaris affects 80% of Americans at some time during their lives.[5]Twenty percent
have severe acne, which can result in permanent physical and mental scarring.
International
Persons of some races are affected more than others. Cystic acne is prevalent in the
Mediterranean region from Spain to Iran.[15]
Race
Acne is common in North American whites. African Americans have a higher prevalence
of pomade acne, likely stemming from the use of hair pomades. Ethnicities with darker
skin are also more prone to postinflammatory hyperpigmentation.[16]
Sex
During adolescence, acne vulgaris is more common in males than in females. In
adulthood, acne vulgaris is more common in women than in men.[17]
Age
Acne or acneform lesions, such as in neonatal cephalic pustulosis, may be present in the
first few weeks and months of life, when a newborn is still under the influence of
maternal hormones and when the androgen-producing portion of the adrenal gland is
disproportionately large.[18]This neonatal acne tends to resolve spontaneously. However,
some neonates may require therapy (eg, topical retinoids).[18]
Adolescent acne usually begins with the onset of puberty, when the gonads begin to
produce and release more androgen hormone.
Acne is not limited to adolescence. Twelve percent of women and 5% of men at aged 25
years have acne. By age 45 years, 5% of both men and women still have acne.[19]
Prognosis
Acne may cause long-lasting and detrimental psychosocial and physical effects. It is
associated with depression and anxiety, regardless of disease severity, although the
psychological effects usually improve with treatment. Furthermore, acne may cause
permanent scarring that is difficult to correct.[20]
In male patients, acne generally clears by early adulthood. Five percent of men still have
acne at age 25 years. Female patients frequently have adult acne. Twelve percent of
women still have acne at age 25 years. Five percent of women still have acne at age 45
years.[19]
The overall prognosis for persons with acne is good.
Patient Education
Patients should be instructed on their morning and evening treatment programs. Retinoid
dermatitis may develop at approximately day 10 of therapy. Patients must be informed of
this in advance so they will not consider this exfoliation an allergy. By skipping a day or
2 and restarting the program slowly, the skin can adapt to this irritation.